Moreover, we observed that the siRNA-TPD52 transfection of CWR22Rν1 cells resulted in tumor growth inhibition with a considerable reduction in the secretion of PSA (prostate-specific antigen) in the serum. This evidence concerns the gene TPD52 and neoplasm.